Loading insider details...
Beta
Latest Form 4 (Jun 15, 2026): Grant/Award of 65,000 ANNX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 15, 2026 | Annexon, Inc. (ANNX) | Grant/Award | 65,000 | n/a |
| Nov 19, 2025 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 1,517 | n/a |
| Jun 9, 2025 | Annexon, Inc. (ANNX) | Grant/Award | 55,000 | n/a |
| Jun 8, 2024 | Annexon, Inc. (ANNX) | Grant/Award | 44,000 | n/a |
| Apr 11, 2024 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 17,500 | n/a |
| Sep 25, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 16,551 | n/a |
| Jun 12, 2023 | Annexon, Inc. (ANNX) | Grant/Award | 24,000 | n/a |
| May 9, 2023 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 8,300 | n/a |
| Jun 13, 2022 | Annexon, Inc. (ANNX) | Grant/Award | 24,000 | n/a |
| Jan 20, 2022 | Annexon, Inc. (ANNX) | Grant/Award | 20,000 | n/a |